3,3',5'-Triiodothyronine concentrations in amniotic fluid at different stages of pregnancy. 1979

E Roti, and F Malavasi, and P Bandini, and G Robuschi, and L Benassi, and A Gnudi

Since it is feasible to detect reverse T3 (rT3) in amniotic fluid, we investigated the possibility as to whether measurements of amniotic rT3 could be useful in diagnosing fetal hypothyroidism during pregnancy. In 55 amniotic fluid samples, obtained at different stages of pregnancy, we have documented increasing concentrations of this hormone. The results obtained are conflicting with previous reports. The reason for this discrepancy is not clear, however methodological differences in rT3 determination should be taken in account. The large scatter of rT3 values in amniotic fluid suggests that the diagnosis of neonatal hypothyroidism based on measurement of rT3 may require caution.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011261 Pregnancy Trimester, First The beginning third of a human PREGNANCY, from the first day of the last normal menstrual period (MENSTRUATION) through the completion of 14 weeks (98 days) of gestation. Early Placental Phase,Pregnancy, First Trimester,Trimester, First,Early Placental Phases,First Pregnancy Trimester,First Pregnancy Trimesters,First Trimester,First Trimester Pregnancies,First Trimester Pregnancy,First Trimesters,Phase, Early Placental,Phases, Early Placental,Placental Phase, Early,Placental Phases, Early,Pregnancies, First Trimester,Pregnancy Trimesters, First,Trimesters, First
D011262 Pregnancy Trimester, Second The middle third of a human PREGNANCY, from the beginning of the 15th through the 28th completed week (99 to 196 days) of gestation. Midtrimester,Pregnancy, Second Trimester,Trimester, Second,Midtrimesters,Pregnancies, Second Trimester,Pregnancy Trimesters, Second,Second Pregnancy Trimester,Second Pregnancy Trimesters,Second Trimester,Second Trimester Pregnancies,Second Trimester Pregnancy,Second Trimesters,Trimesters, Second
D011263 Pregnancy Trimester, Third The last third of a human PREGNANCY, from the beginning of the 29th through the 42nd completed week (197 to 294 days) of gestation. Pregnancy, Third Trimester,Trimester, Third,Last Trimester,Last Trimesters,Pregnancies, Third Trimester,Pregnancy Trimesters, Third,Third Pregnancy Trimester,Third Pregnancy Trimesters,Third Trimester,Third Trimester Pregnancies,Third Trimester Pregnancy,Third Trimesters,Trimester, Last,Trimesters, Last,Trimesters, Third
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000653 Amniotic Fluid A clear, yellowish liquid that envelopes the FETUS inside the sac of AMNION. In the first trimester, it is likely a transudate of maternal or fetal plasma. In the second trimester, amniotic fluid derives primarily from fetal lung and kidney. Cells or substances in this fluid can be removed for prenatal diagnostic tests (AMNIOCENTESIS). Amniotic Fluid Index,Amniotic Fluid Indices,Amniotic Fluids,Fluid Index, Amniotic,Fluid Indices, Amniotic,Fluid, Amniotic,Fluids, Amniotic,Index, Amniotic Fluid,Indices, Amniotic Fluid
D014284 Triiodothyronine A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3. Liothyronine,T3 Thyroid Hormone,3,3',5-Triiodothyronine,Cytomel,Liothyronine Sodium,Thyroid Hormone, T3
D014285 Triiodothyronine, Reverse A metabolite of THYROXINE, formed by the peripheral enzymatic monodeiodination of T4 at the 5 position of the inner ring of the iodothyronine nucleus. 3,3',5'-Triiodothyronine,Reverse T3 Thyroid hormone,Reverse Triiodothyronine,3,3,5 Triiodothyronine,3,3,5-Triiodothyronine

Related Publications

E Roti, and F Malavasi, and P Bandini, and G Robuschi, and L Benassi, and A Gnudi
June 1985, Nihon Sanka Fujinka Gakkai zasshi,
E Roti, and F Malavasi, and P Bandini, and G Robuschi, and L Benassi, and A Gnudi
October 1983, Medical hypotheses,
E Roti, and F Malavasi, and P Bandini, and G Robuschi, and L Benassi, and A Gnudi
April 1980, The Journal of clinical endocrinology and metabolism,
E Roti, and F Malavasi, and P Bandini, and G Robuschi, and L Benassi, and A Gnudi
July 1977, European journal of pediatrics,
E Roti, and F Malavasi, and P Bandini, and G Robuschi, and L Benassi, and A Gnudi
October 1980, Clinica chimica acta; international journal of clinical chemistry,
E Roti, and F Malavasi, and P Bandini, and G Robuschi, and L Benassi, and A Gnudi
January 1982, Clinica chimica acta; international journal of clinical chemistry,
E Roti, and F Malavasi, and P Bandini, and G Robuschi, and L Benassi, and A Gnudi
January 1991, Journal of cardiovascular pharmacology,
E Roti, and F Malavasi, and P Bandini, and G Robuschi, and L Benassi, and A Gnudi
January 1983, Endokrynologia Polska,
E Roti, and F Malavasi, and P Bandini, and G Robuschi, and L Benassi, and A Gnudi
December 1983, The Indian journal of medical research,
E Roti, and F Malavasi, and P Bandini, and G Robuschi, and L Benassi, and A Gnudi
August 1993, Endocrine journal,
Copied contents to your clipboard!